 PARIS CAMBRIDGE, Mass.--BUSINESS WIRE--- NBTX NBTXNews--Regulatory News: NANOBIOTIX Euronext: NANO NASDAQ: NBTX the Company, a late-clinical stage biotechnology company pioneering physics-based approaches to expand treatment possibilities for patients with cancer, today announced that it will report its financial results for half-year ending June 30, 2022, on Wednesday, September 28, 2022, after the close of the US market. The announcement will be followed by a conference call and live audio webc 